Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia

被引：4
|
作者：
Puri, Alka [1 ]
Mahmood, Shawn [1 ]
Maertens, Bernadette [1 ]
Davare, Monika [2 ]
Kurtz, Stephen E. [1 ]
Tognon, Cristina E. [1 ,3 ]
Eden, Christopher O. [1 ]
Elferich, Johannes [4 ]
Shinde, Ujwal [4 ]
Druker, Brian J. [1 ,3 ]
Singer, Jack W. [5 ]
Agarwal, Anupriya [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Pape Pediat Res Inst, Dept Pediat, Portland, OR USA
[3] Howard Hughes Med Inst, Portland, OR USA
[4] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR USA
[5] CTI BioPharma Corp, Seattle, WA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.3514.3514
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3514
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
    Yosuke Tanaka
    Reina Takeda
    Tsuyoshi Fukushima
    Keiko Mikami
    Shun Tsuchiya
    Moe Tamura
    Keito Adachi
    Terumasa Umemoto
    Shuhei Asada
    Naoki Watanabe
    Soji Morishita
    Misa Imai
    Masayoshi Nagata
    Marito Araki
    Hitoshi Takizawa
    Tomofusa Fukuyama
    Chrystelle Lamagna
    Esteban S. Masuda
    Ryoji Ito
    Susumu Goyama
    Norio Komatsu
    Tomoiku Takaku
    Toshio Kitamura
    Nature Communications, 13
  • [2] Eliminating chronic myeloid leukemia stem cells by IRAK1/4 inhibitors
    Tanaka, Yosuke
    Takeda, Reina
    Fukushima, Tsuyoshi
    Mikami, Keiko
    Tsuchiya, Shun
    Tamura, Moe
    Adachi, Keito
    Umemoto, Terumasa
    Asada, Shuhei
    Watanabe, Naoki
    Morishita, Soji
    Imai, Misa
    Nagata, Masayoshi
    Araki, Marito
    Takizawa, Hitoshi
    Fukuyama, Tomofusa
    Lamagna, Chrystelle
    Masuda, Esteban S.
    Ito, Ryoji
    Goyama, Susumu
    Komatsu, Norio
    Takaku, Tomoiku
    Kitamura, Toshio
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] Discovery of IRAK1/4/pan-FLT3 Kinase Inhibitors as Treatments for Acute Myeloid Leukemia
    Hoyt, Scott B.
    Finocchio, Chris J.
    Croll, Elizabeth
    Tawa, Gregory J.
    Li, Huixu
    Ma, Li
    Li, Kaikai
    Liu, Li
    Li, Ranran
    Zhang, Xiaohu
    Wilson, Kelli
    Xu, Xin
    Shah, Pranav
    Williams, Jordan
    Fang, Yuhong
    Bolanos, Lyndsey C.
    Gracia-Maldonado, Gabriel
    Kolt, Amal
    Robinson, Christina
    Free, Jessica
    Edmondson, Elijah F.
    Difilippantonio, Simone
    Jones, LaQuita M.
    Culver-Cochran, Ashley E.
    Rosenbaum, Jan S.
    Starczynowski, Daniel T.
    Thomas, Craig J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (11): : 1843 - 1851
  • [4] HDAC Inhibitors in Acute Myeloid Leukemia
    San Jose-Eneriz, Edurne
    Gimenez-Camino, Naroa
    Agirre, Xabier
    Prosper, Felipe
    CANCERS, 2019, 11 (11)
  • [5] Inhibition of IRAK1 As a Novel Therapeutic Strategy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Rhyasen, Garrett
    Bolanos, Lyndsey
    Fang, Jing
    Rigolino, Carmen
    Cortelezzi, Agostino
    Oliva, Esther Natalie
    Cuzzola, Mariella
    Starczynowski, Daniel T.
    BLOOD, 2011, 118 (21) : 281 - 281
  • [6] Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
    Dussiau, Charles
    Trinquand, Amelie
    Lhermitte, Ludovic
    Latiri, Mehdi
    Simonin, Mathieu
    Cieslak, Agata
    Bedjaoui, Nawel
    Villarese, Patrick
    Verhoeyen, Els
    Dombret, Herve
    Ifrah, Norbert
    Macintyre, Elizabeth
    Asnafi, Vahid
    ONCOTARGET, 2015, 6 (22) : 18956 - 18965
  • [7] The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair
    Maiso, P.
    Colado, E.
    Ocio, E. M.
    Garayoa, M.
    Martin, J.
    Atadja, P.
    Pandiella, A.
    San-Miguel, J. F.
    LEUKEMIA, 2009, 23 (12) : 2265 - 2274
  • [8] The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair
    P Maiso
    E Colado
    E M Ocio
    M Garayoa
    J Martín
    P Atadja
    A Pandiella
    J F San-Miguel
    Leukemia, 2009, 23 : 2265 - 2274
  • [9] IL-1 Via IRAK1/4 Sustains Acute Myeloid Leukemia Stem Cells Following Treatment and Relapse
    Ho, Tzu-Chieh
    Kawano, Hiroki
    LaMere, Mark W.
    Guo, Naxin
    Chiu, Yu-Chiao
    Wang, Jian
    Jordan, Craig T.
    Dokholyan, Nikolay V.
    Calvi, Laura M.
    Singh, Rakesh Kumar
    Becker, Michael W.
    BLOOD, 2021, 138
  • [10] Pacritinib, a Dual FLT3/JAK2 Inhibitor, Reduces Irak-1 Signaling in Acute Myeloid Leukemia
    Cleary, Megan M.
    Thompson, Rhese
    Mahmood, Shawn
    Davare, Monika
    Kurtz, Steve
    Elferich, Johannes
    Shinde, Ujwal
    Druker, Brian J.
    Singer, Jack
    Agarwal, Anupriya
    BLOOD, 2015, 126 (23)
12345